fbpx

Welcome! We just launched the new Life Science and Food Industry Podcasts. Available everywhere!

X

Teatis Carb-Blocking Teas Aim to Help Diabetics Avoid Blood Sugar Spikes

Teatis Carb-Blocking Teas Aim to Help Diabetics Avoid Blood Sugar Spikes

Teatis is a superfood powder designed to help diabetic consumers manage blood sugar levels using a Japanese ingredient that blocks the digestion of carbohydrates from food.

Teatis, a New-York based company, is the maker of superfood powders for diabetic consumers. They announced the close of their seed funding round last week, during which they raised $700,000, bringing the company’s total funding of $1 million. Hiroshi Takatoh is the entrepreneur behind this brand.

Takatoh noticed that there is a need for convenient and nutritious food for critically ill consumers. He saw this need after losing his wife to cancer, before which he acted as her caretaker while also running a tech company.

The company has created a plant-based sugar-blocking superfood powder designed to help diabetic consumers manage blood sugar levels. The idea began in 2017, but the company wasn’t fully operational until April 2021. The team is made up of a group of doctors and registered nutritionists.

Takatoh, along with his team, crafted a product to target diabetic consumers who don’t have time to cook but wanted to consume nutritious and natural ingredients that help with carbohydrate digestion and the release of glucose.

“With millions of diabetics living in the United States, there is significant demand for diabetic-friendly foods that are nutritious, convenient, and functional,” said Takatoh in a press release. “Our team of doctors has worked for years to perfect our product line, and this is just the beginning. We plan on building out a comprehensive one-stop-shop for diabetic health.”


Related: Laird Superfood Debuts Hot Chocolate Made with Functional Mushrooms


They want to help the 122 million diabetic and pre-diabetic individuals work towards better prevention against, and treatment of, the common disease. The powders include a Japanese ingredient known as arame, a seaweed extract that inhibits both α-amylase and α-glucosidase, two enzymes important in the digestion of carbohydrates. The company claims that arame is clinically proven to suppress the absorption of sugar and moderate blood sugar levels, and shares publications to support this on their website; however, the ingredient has not been evaluated by the US Food and Drug Administration.

Teatis is backed up by promising investors that support and promote trans-pacific start-ups. Genesia Ventures, Ryo Ishizuka and Takuya Noguchi led the round along with seven other angel investors. The money gathered from the seed round will help the company advance its production and marketing in the US.

Teatis has two flavors: Matcha and Ginger & Tumeric, both of which contain no chemical ingredients or sweeteners. Both are sold for the price of $29.99, and they can be bought online through the company’s website.